Elin is a Post Doctoral Research Fellow in Melanoma within the School of Medical Sciences.
PhD (Doctoral Degree), South Africa, 2008.
M (Master Degree), Cuba, 2001.
B (Bachelor Degree), Cuba, 1997.
Recent Research Grants
Characterisation of Melanoma Circulating Tumour Cells for Personalised Treatment, Cancer Research Trust, Postdoctoral Fellowship,
2014 - 2019, $830,000.
Circulating Tumour DNA to Predict and Monitor Treatment Response and Detect
Acquired Resistance in Patients with Metastatic Melanoma, Ramaciotti Foundation, Grant,
2015 - 2018, $99,911.
Genetic Analysis of Blood Markers for Prognosis in Patients with Uveal Melanoma, University of Western Australia, Raine Foundation Grant,
2016 - 2018, $100,000.
Blood Based Biomarkers Predictive of Treatment Response in Melanoma, Cancer Council of WA Inc, Grant,
2016 - 2018, $246,822.
Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip, Cancer Council of WA Inc, Grant - Early Career Investigator,
2016 - 2017, $35,000.
Using a Functional Protein Array to Identify Autoantibody Biomarkers with Diagnostic Potential for Melanoma, National Health and Medical Research Council, Development Grants,
2014 - 2017, $778,368.
Circulating Melanoma Cells as Predictive Biomarkers of Treatment Response and Disease Status, Cancer Council of WA Inc, Grant,
2015 - 2017, $111,519.
Melanoma Mutation Profiling For Personalised Treatment, National Health and Medical Research Council, Project Grants,
2013 - 2016, $765,359.
Mass Cytometry: A breakthrough in multidimensional systems biology, Australian Research Council, Grant - Linkage (Infrastructure),
2015 - 2016, $1,081,489.
Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab, Merck Sharp and Dohme (Australia) Pty Ltd, Grant,
2015 - 2016, $73,300.
Circulating Tumour Cells (CTCs) as a diagnostic tool to monitor disease progression in melanoma patients, Edith Cowan University, ECU Industry Collaboration Grant - 2015 (Round 1),
2015 - 2016, $137,227.
Detection of Vemurafenib Resistance in Circulating Tumour Cells for Personalised Treatment of Melanoma, Harry Perkins Institute of Medical Research, Scott Kirkbride Melanoma Research Centre - Discovery Research Priming Grant,
2013 - 2014, $68,182.
Genetic Analysis of Melanoma Cells in Blood For Personalised Treatment Management, Edith Cowan University, ECU Early Career Researcher Grant - 2013,
2013 - 2014, $24,083.
Detection of stem cell markers expression in circulating melanoma cells using multiparameter flow cytometry as a prognosis tool, Edith Cowan University, ECU Early Career Researcher Grant - 2012 (Round 1),
2012 - 2013, $19,480.
Expanding Capacity and Capability in Western Australian Flow Cytometry for Earth, Oceans, Environmental and Biomedical Science: State-of-the-Art Four Laser and 12 Colour Analysis, Australian Research Council, Grant - Linkage (Infrastructure),
2012 - 2013, $598,000.
Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research, National Health and Medical Research Council, Equipment Grant 2011,
2011 - 2012, $10,927.
Recent Publications (within the last five years)
Gray, E., Reid, A., Bowyer, S., Calapre, L., Siew, K., Pearce, R., Cowell, L., Frank, M., Millward, M., Ziman, M., (2015), Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology, 135(8), 2040-2048, London, United Kingdom, DOI: 10.1038/jid.2015.127.
Reid, A., Freeman, J., Millward, M., Ziman, M., Gray, E., (2015), Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clinical Biochemistry, 48(15), 999-1002, Philadelphia, USA, DOI: 10.1016/j.clinbiochem.2014.12.007.
Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, DOI: 10.1186/1471-2407-14-423.
Moore, PL., Sheward, D., Nonyane, M., Ranchobe, N., Hermanus, T., Gray, E., Karim, SS., Williamson, C., Morris, L., (2013), Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. Journal of Virology, 87(9), 4882-4894, United States, DOI: 10.1128/JVI.03424-12.
Wibmer, C., Bhiman, J., Gray, E., Tumba, N., Abdool Karim, SS., Williamson, C., Morris, L., Moore, P., (2013), Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes. PLoS Pathogens, 9(10), 16p., United States, DOI: 10.1371/journal.ppat.1003738.
Calapre, L., Gray, E., Ziman, M., (2013), Heat stress: a risk factor for skin carcinogenesis. Cancer Letters, 337(1), 35-40, Ireland.
Klinac, D., Gray, E., Milward, M., Ziman, M., (2013), Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Frontiers in Oncology, 3(March 2013), Article 00054, DOI: 10.3389/fonc.2013.00054.
Lacerda, M., Moore, P., Ngandu, N., Seaman, M., Gray, E., Murrell, B., Krishnamoorthy, M., Nonyane, M., Madiga, M., Wibmer, C., Sheward, D., Bailer, R., Gao, H., Greene, K., Karim, S., Mascola, J., Korber, B., Montefiori, D., Morris, L., Williamson, C., Seoighe, C., (2013), Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Virology Journal, 10(Article no. 347), 18 p., London, United Kingdom, DOI: 10.1186/1743-422X-10-347.
Freeman, J., Gray, E., Milward, M., Pearce, R., Ziman, M., (2012), Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine, 10(1), art. no. 192 , United Kingdom, DOI: 10.1186/1479-5876-10-192.
Research Student Supervision
Doctor of Philosophy, Heat Stress: A Risk Factor For Skin Carcinogenesis